Advertisement

Becton, Dickinson and Company BDX

Set alert

Price alert · BDX

All alert types
197.88 USD -0.46 -0.23%

At close · Oct 30

197.88 0.00 0.00%

After hours · Oct 30, 4:05 PM ET

Bid
197.74 × 100
Ask
197.95 × 100
197.06 Day range 199.94
138.67 52-week range 200.42
YTD
+29.70%
1 year
+40.32%
Open
199.77
Prev close
198.34
Mkt cap
53.90B
Vol
2.92M
Avg vol
1.73M
EPS
4.30
P/E
46.02
Div yield
2.12%
More statistics
Low
197.06
High
199.94
Forward P/E
14.87
Beta
0.28
Short ratio
4.88
Inst. own
99.68%
Dividend
4.20
Ex-div date
Sep 8, 2026
Earnings
Nov 5, 2026
50-d avg
186.39
200-d avg
165.81
1y target
195.57

5Y chart

Chart tools
Interval

Events in this range
  • Dec 9, 2021Dividend: 0.87
  • Mar 9, 2022Dividend: 0.87
  • Apr 1, 2022Split: 1025 for 1000
  • Jun 8, 2022Dividend: 0.87
  • Sep 8, 2022Dividend: 0.87
  • Dec 8, 2022Dividend: 0.91
  • Dec 30, 2022Dividend: 0.91
  • Mar 9, 2023Dividend: 0.91
  • Jun 8, 2023Dividend: 0.91
  • Sep 7, 2023Dividend: 0.91
  • Dec 7, 2023Dividend: 0.95
  • Mar 7, 2024Dividend: 0.95
  • Jun 7, 2024Dividend: 0.95
  • Jun 10, 2024Dividend: 0.95
  • Sep 9, 2024Dividend: 0.95
  • Dec 9, 2024Dividend: 1.04
  • Mar 10, 2025Dividend: 1.04
  • Jun 9, 2025Dividend: 1.04
  • Aug 7, 2025Earnings: 3.68; estimate 3.4; surprise 8.24%
  • Sep 8, 2025Dividend: 1.04
  • Nov 6, 2025Earnings: 3.96; estimate 3.92; surprise 1.02%
  • Dec 8, 2025Dividend: 1.05
  • Feb 9, 2026Earnings: 2.91; estimate 2.21; surprise 31.67%
  • Mar 10, 2026Dividend: 1.05
  • May 7, 2026Earnings: 2.9; estimate 2.78; surprise 4.32%
  • Jun 9, 2026Dividend: 1.05
  • Aug 6, 2026Earnings: 3.23; estimate 3.14; surprise 2.87%
  • Aug 7, 2026Rating: Piper Sandler · Neutral → Neutral
  • Aug 7, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Aug 7, 2026Rating: Citigroup · Buy → Buy
  • Aug 13, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Aug 31, 2026Rating: B of A Securities · Neutral → Neutral
  • Sep 9, 2026Dividend: 1.05
  • Oct 7, 2026Rating: Barclays · — → Underweight
  • Nov 5, 2026Earnings: —; estimate 4.07; surprise —%
Signals (111)
NameDateAgo
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishSep 28, 20261 month ago
RSI: OverboughtAug 17, 20262 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJul 13, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 1, 20265 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BearishMar 16, 20267 months ago
MACD: Sell SignalMar 16, 20267 months ago
SMA: BearishMar 9, 20267 months ago
RSI: OverboughtFeb 16, 20268 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishOct 27, 20251 year ago
SMA: BullishOct 13, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BearishSep 8, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BullishAug 18, 20251 year ago
MACD: Buy SignalJul 14, 20251 year ago
SMA: BullishJun 30, 20251 year ago
RSI: OversoldJun 9, 20251 year ago
RSI: OversoldApr 28, 20251 year ago
MACD: Sell SignalFeb 24, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 6, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago
SMA: BullishDec 23, 20241 year ago
MACD: Sell SignalNov 4, 20241 year ago
SMA: BearishOct 28, 20242 years ago
SMA: BearishOct 28, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BearishOct 7, 20242 years ago
SMA: BullishSep 23, 20242 years ago
SMA: BullishSep 23, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BullishAug 26, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BullishJul 22, 20242 years ago
SMA: BullishJul 22, 20242 years ago
MACD: Buy SignalJul 22, 20242 years ago
MACD: Sell SignalJul 1, 20242 years ago
SMA: BearishJun 24, 20242 years ago
SMA: BearishJun 24, 20242 years ago
SMA: BullishJun 17, 20242 years ago
SMA: BullishJun 17, 20242 years ago
SMA: BearishJun 10, 20242 years ago
SMA: BearishJun 10, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BullishJun 3, 20242 years ago
MACD: Buy SignalJun 3, 20242 years ago
MACD: Sell SignalMay 20, 20242 years ago
MACD: Buy SignalMay 13, 20242 years ago
MACD: Sell SignalApr 22, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BullishMar 25, 20242 years ago
SMA: BullishMar 18, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BullishMar 4, 20242 years ago
SMA: BearishFeb 26, 20242 years ago
SMA: BullishFeb 5, 20242 years ago
MACD: Buy SignalFeb 5, 20242 years ago
SMA: BearishJan 8, 20242 years ago
SMA: BullishDec 18, 20232 years ago
SMA: BearishOct 9, 20233 years ago
SMA: BullishOct 2, 20233 years ago
SMA: BearishSep 25, 20233 years ago
MACD: Sell SignalSep 11, 20233 years ago
SMA: BearishSep 4, 20233 years ago
SMA: BullishJun 12, 20233 years ago
MACD: Buy SignalJun 12, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BearishMay 22, 20233 years ago
MACD: Sell SignalMay 22, 20233 years ago
MACD: Buy SignalApr 3, 20233 years ago
SMA: BullishMar 27, 20233 years ago
SMA: BullishMar 27, 20233 years ago
MACD: Sell SignalFeb 20, 20233 years ago
SMA: BearishFeb 13, 20233 years ago
SMA: BearishJan 30, 20233 years ago
SMA: BullishNov 28, 20223 years ago
MACD: Buy SignalNov 28, 20223 years ago
SMA: BullishNov 21, 20223 years ago
SMA: BearishSep 19, 20224 years ago
MACD: Sell SignalSep 19, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BearishAug 22, 20224 years ago
MACD: Buy SignalAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BearishJul 4, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BearishMay 30, 20224 years ago
SMA: BearishApr 18, 20224 years ago
SMA: BullishMar 21, 20224 years ago
SMA: BearishMar 7, 20224 years ago

Key statistics

Market cap
53.88B
Enterprise value
70.12B
Trailing P/E
46.00
Forward P/E
14.87
PEG ratio
1.11
Price / sales
2.40
Price / book
2.21
EPS (TTM)
4.30
Beta
0.28
Dividend yield
2.12%
Payout ratio
72.49%
Profit margin
4.19%
Revenue (TTM)
22.48B
Revenue growth
5.40%
Free cash flow
4.48B
Total cash
709.00M
Total debt
16.81B
Return on equity
6.61%
Shares outstanding
272.39M
Short % of float
3.73%
50-day average
186.39
200-day average
165.81

Analyst view

Consensus: buy

Buy
Price target (mean) 195.57 -1.2% downside
Target (low)
165.00
Target (mean)
195.57
Target (high)
225.00
Ratings (0m) 16 8 buy · 7 hold · 1 sell
  • Strong buy1
  • Buy7
  • Hold7
  • Sell0
  • Strong sell1

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 4.07.

Earnings history

Financials — quick view

All financials
BDX Revenue — quarterly 4.98B
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
BDX Net income — quarterly 377.00M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
BDX EPS — quarterly 1.37
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026

Earnings

BDX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20264.07———
Aug 6, 2026Jun 30, 20263.143.23+0.09+2.87%
May 7, 2026Mar 31, 20262.782.90+0.12+4.32%
Feb 9, 2026Dec 31, 20252.212.91+0.70+31.67%
Nov 6, 2025Sep 30, 20253.923.96+0.04+1.02%
Aug 7, 2025Jun 30, 20253.403.68+0.28+8.24%

Upgrades / downgrades

BDX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026Barclaysinit—Underweight
Aug 31, 2026B of A SecuritiesmainNeutralNeutral
Aug 13, 2026RBC CapitalmainSector PerformSector Perform
Aug 7, 2026CitigroupmainBuyBuy
Aug 7, 2026RBC CapitalmainSector PerformSector Perform
Aug 7, 2026Piper SandlermainNeutralNeutral

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
bd.com

News

Your note

Sign in to keep a note on BDX — it syncs with the Stock Master app.

Insider holders

BDX insider holders
InsiderRelationLatest transactionDateShares held
DELOREFICE CHRISTOPHERChief Financial OfficerStock Award(Grant)Nov 25, 202522,982
FELD MICHAELOfficerSaleOct 25, 202619,568
FRASER CLAIREDirectorSaleSep 9, 202522,226
GOETTE ROLANDOfficerSaleAug 10, 202616,635
JONES CHRISTOPHER IAN MONTAGUEDirectorStock Award(Grant)Jan 26, 202624,304
MUHSIN BILALOfficerStock Award(Grant)Jun 30, 202641,359

Institution ownership

BDX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.93%24,592,1664.86BJun 29, 2026
Vanguard Capital Management LLC6.53%17,987,8343.56BJun 29, 2026
State Street Corporation5.44%15,000,0642.97BJun 29, 2026
Vanguard Portfolio Management LLC5.43%14,974,1362.96BJun 29, 2026
First Eagle Investment Management, LLC5.01%13,815,3352.73BJun 29, 2026
Invesco Ltd.3.23%8,898,4881.76BJun 29, 2026

Fund ownership

BDX fund ownership
Holder% heldSharesValueReported
First Eagle Funds-First Eagle Global Fund3.32%9,151,9951.81BJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%8,747,2611.73BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%7,136,0261.41BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.17%5,970,1671.18BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.32%3,629,584717.97MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%3,576,755707.52MAug 30, 2026
Advertisement